NAR Cancer
Q1 Journal
Open Access
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q1
└
Oncology
Q1
Publisher
SJR 2025
2.019
Q1
SJR Score
H-Index
30
Citations / Doc (2yr)
4.12
Total Docs. (latest)
57
Total Citations (3yr)
631
Publication type
Journals
ISSN
26328674
Coverage
2019-2026
Journal Rank
#1,426
Subject Categories
Cancer Research
Q1
Oncology
Q1
Subject Areas
Aims & Scope
Papers should provide new insights into broadly applicable principles or mechanisms that underpin malignant phenotypes in one or more cancer types, with a focus on mechanisms leading to dysregulation of gene expression, altered chromatin features, or aberrant DNA methylation landscapes.
Findings must demonstrate relevance to the pathological context in which the process occurs.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Medline
PubMed
Embase
Detailed Metrics
| Total Docs. (latest) | 57 |
| Total Docs. (3 years) | 155 |
| Total Refs. | 4,552 |
| Total Citations (3 years) | 631 |
| Citable Docs. (3 years) | 153 |
| Citations / Doc. (2 years) | 4.12 |
| Ref. / Doc. | 79.86 |
| % Female | 47.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.